Couverture de 3 Things

3 Things

3 Things

De : Express Audio
Écouter gratuitement

À propos de ce contenu audio

 Our flagship daily news show, where we talk to in-house experts about what is going on and why you need to care about it.Copyright Express Audio Politique et gouvernement
Épisodes
  • Iran war's impact, fighting childhood obesity, and India-Pak airspace

    Iran war's impact, fighting childhood obesity, and India-Pak airspace
    Apr 22 2026
    First, we speak to The Indian Express’ Udit Misra about the growing debate over India’s GDP numbers, after the new data series raised fresh questions about how accurately the country’s economic growth is being measured.

    Next, we talk to The Indian Express’ Rinku Ghosh about childhood obesity and how different countries are rethinking the food environment around children, with schools and cities experimenting with new models to improve nutrition and long-term health outcomes. (15:20)

    And in the end, we look at the year-long airspace standoff between India and Pakistan, and how the continued ban on overflights is quietly imposing high costs on Indian airlines. (29:42)


    Hosted by Ichha Sharma
    Produced and written by Shashank Bhargava, Niharika Nanda and Ichha Sharma
    Edited and mixed by Suresh Pawar
    Afficher plus Afficher moins
    33 min
  • The Catch Up: India–Pakistan Airspace ban extended (21 April)

    The Catch Up: India–Pakistan Airspace ban extended (21 April)
    Apr 21 2026
    The headlines of the day by The Indian Express
    Afficher plus Afficher moins
    4 min
  • Express Investigation: How a life saving cancer drug is counterfeited

    Express Investigation: How a life saving cancer drug is counterfeited
    Apr 21 2026
    While advances in early detection and treatment have reduced cancer deaths in many parts of the world, that progress hasn’t reached everyone. In India, cancer cases are rising, with nearly 14 lakh diagnoses in 2022—and access to life-saving drugs remains a major challenge.

    An investigation by The Indian Express, in collaboration with the International Consortium of Investigative Journalists, reveals how one of the world’s leading cancer drugs, Keytruda, remains out of reach for many patients. It also uncovers how gaps in regulation have allowed counterfeit versions of the drug to enter the market.

    Drawing on over 12,000 documents and records of more than 150 patients, the investigation lays bare the scale of the problem—and its human cost. In this episode, we speak with The Indian Express' Kaunain Sheriff and Anonna Dutt, who led this investigation.

    Hosted and produced by Shashank Bhargava
    Edited and mixed by Suresh Pawar
    Afficher plus Afficher moins
    37 min
Aucun commentaire pour le moment